ArticlePharmacology research & perspectives2018

Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues.

Sharath S Hegde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.